GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term ...
Eight New York broadcasters finished NYSBA's Rising Leaders Fellowship, an MBA-style program on revenue, news, accounting, ...
Evangelical churches like Rick Warren’s wouldn’t be as massive as they are with real retention of members over time without a serious plan for member leadership development. The Left could learn from ...
Meta is introducing a new category of shares to support its AI projects, investing billions into the rapidly evolving sector.
Kargil Subordinate Service Recruitment Board (LAHDC KSSRB) has released the Recruitment 2026 notification for 181 vacancies ...
The Cavalier Daily spoke with three recent graduates of the Class of 2026 about the months since they left Grounds — what ...
A 2020 law meant to pave the way for the redevelopment of the historic Hill Top House Hotel in Harpers Ferry was the focus of ...
Tenants of three Long Island City apartment buildings are alleging that the developer that owns their sites had overcharged rent by more than $50 million in a ...
VMS063 is a novel, potential first- and best-in-class monoclonal antibody investigational candidate discovered by Invivyd VMS063 demonstrated potent in vitro antiviral activity against contemporary ...
Cops have been called, lawsuits have been filed and a global investment company is trying to secure more seats on the ...
Star Haven Manufactured Home Community will become a neighborhood of townhomes. But it will take a few years. Star City Town Council Tuesday voted 5-1 to approve a request to rezone to trailer park ...
RxMP Therapeutics, Inc. ("RxMP"), a late pre-clinical stage therapeutics company developing novel therapies for the rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results